The HNF1/HNF4-dependent We2 element of woodchuck hepatitis virus controls viral replication and can activate the N-myc2 promoter

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 8571-8583

  Fourel, Geneviève ^a   Ringeisen, François ^a   Flajolet, Marc ^a   Tronche, François ^a,b   Pontoglio, Marco ^a   Tiollais, Pierre ^a   Buendia, Marie Annick ^a  

^a INSTITUT PASTEUR   (France)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ANIMAL CELL; ARTICLE; HEPATITIS VIRUS; LIVER CARCINOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATOR GENE; TRANSCRIPTION REGULATION; VIRUS CARCINOGENESIS; VIRUS REPLICATION;

EID: 0029914172     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.8571-8583.1996     Document Type: Article

References (88)

1. Adams, C. C., and J. L. Workman. 1995. Binding of disparate transcriptional activators to nucleosomal DNA is inherently cooperative. Mol. Cell. Biol. 15:1405-1421.
2. Athas, G. B., P. Lobelle-Rich, and L. S. Levy. 1995. Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors. J. Virol. 69:3324-3332.
3. Beasley, R. P., C. C. Lin, L. Y. Hwang, and C. S. Chien. 1981. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet ii:129-1133.
4. Buendia, M. A. 1994. Animal models for hepatitis B virus and liver cancer, p. 211-224. In C. Bréchot (ed.), Primary liver cancer etiological and progression factors. CRC Press, Boca Raton, Fla.
5. Cereghini, S., M. Blumenfeld, and M. Yaniv. 1988. A liver-specific factor essential for albumin transcription differs between differentiated and dedifferentiated rat hepatoma cells. Genes Dev. 2:957-974.
6. Chen, I.-H., C.-J. Huang, and L.-P. Ting. 1995. Overlapping initiator and a TATA box functions in the basal core promoter of hepatitis B virus. J. Virol. 69:3647-3657.
7. Chouard, T., M. Blumenfeld, I. Bach, J. Vanderkerkhove, S. Cereghini, and M. Yaniv. 1990. A distal dimerization domain is essential for DNA-binding by the atypical HNF1 homcodomain. Nucleic Acids Res. 18:5853.
8. Cleary, M. A., S. Stern, M. Tanaka, and W. Herr. 1993. Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct-1 and VP16 corecruitment. Genes Dev. 7:72-83.
9. Costa, R. H., and D. R. Grayson. 1991. Site-directed mutagenesis of hepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region. Nucleic Acids Res. 19:4139-4145.
10. Costa, R. H., D. R. Grayson, and J. E. J. Uarnell. 1989. Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and α1-antitrypsin genes. Mol. Cell. Biol. 9:1415-1425.
11. Courtois, G., J. G. Morgan, L. A. Campbell, G. Fourel, and G. R. Crabtree. 1987. Interaction of a liver-specific nuclear factor with the fibrinogen and α1-antitrypsin promoters. Science 238:688-692.
12. Crossley, M., and G. G. Brownlee. 1990. Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B. Nature (London) 345:444-446.
13. Crossley, M., M. Ludwig, K. M. Stowell, P. DeVos, K. Olek, and G. G. Brownlee. 1992. Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter. Science 257:377-379.
14. Dalmon, J., M. Laurent, and G. Courtois. 1993, The human β-fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Mol. Cell. Biol. 13:1183-1193.
15. Das, G., C. Hinkley, and W. Herr. 1995. Basal promoter elements as a selective determinant of transcriptional activator function. Nature (London) 374:657-660.
16. Dejean, A., L. Bougueleret, K. H. Grzeschik, and P. Tiollais. 1986. Hepatitis B virus DNA integration in a sequence homologous to v-erbA and steroid receptor genes in a hepatocellular carcinoma. Nature (London) 322:70-72.
17. Etiemble, J., C. Degott, C. A. Renard, G. Fourel, B. Shamoon, L. Vitviski-Trépo, T. Y. Hsu, P. Tiollais, and M. A. Buendia. 1994. Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion. Oncogene 9:727-737.
18. Fourel, G. Unpublished data.
19. Fourel, G., J. Couturier, Y. Wei, F. Apiou, P. Tiollais, and M. A. Buendia. 1994. Evidence for long-range oncogene activation by hepadnavirus insertion. EMBO J. 13:2526-2534.
20. Fourel, G., and P. Tiollais. 1994. Molecular biology of the hepatitis B virus, p. 89-123. In C. Bréchot (ed.). Human primary liver cancer: etiological and progression factors. CRC Press, Boca Raton, Fla.
21. Fourel, G., P. Tiollais, and M. A. Buendia. 1990. Nucleotide sequence of the woodchuck N-myc gene (WN-mycl). Nucleic Acids Res. 18:4918.
22. Fourel, G., C. Transy, B. C. Tennant, and M. A. Buendia. 1992 Expression of the woodchuck N-myc2 retroposon in brain and in liver tumors is driven by a cryptic N-myc promoter. Mol. Cell. Biol. 12:5336-5344.
23. Fourel, G., C. Trépo, L. Bougueleret, B. Henglein, A. Ponzetto, P. Tiollais, and M. A. Buendia. 1990. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature (London) 347:294-298.
24. Galibert, F., T. N. Chen, and E. Mandart. 1982. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence. J. Virol. 41:51-65.
25. Girones, R., P. J. Cote, W. E. Hornbuckle, B. C. Tennant, J. L. Gerin, R. H. Purcell, and R. H. Miller. 1989. Complete nucleotidc sequence of a molecular clone of woodchuck hepatitis virus that is infectious in the natural host. Proc. Natl. Acad. Sci. USA 86:1846-1849.
26. Gloss, B, M. Yeo-Gloss, M. Meisterernst, L. Rogge, E. L. Winnacker, and B. Hu. 1989. Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. Nucleic Acids Res. 17:3519-3533.
27. Gorski, K., M. Carneiro, and U. Schibler. 1986. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47:767-776.
28. Grayson, J., R. S. Williams, Y.-T. Yu, and R. Bassel-Duby. 1995. Synergistic interactions between heterologous upstream activation elements and specific TATA sequences in a muscle-specific promoter. Mol. Cell. Biol. 15:1870-1878.
29. Günther, S., N. Piwon, A. Iwanska, R. Schilling, H. Meisel, and H. Will. 1996. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J. Virol. 70:8318-8331.
30. Guo, W., M. Chen, T. S. B. Yen, and J.-H. Ou. 1993. Hepatocyte-specific expression of the hepatitis B virus core promoter depends on both positive and negative regulation. Mol. Cell. Biol. 13:443-448.
31. Hansen, L. J., B. C. Tennant, C. Seeger, and D. Ganem. 1993. Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses. Mol. Cell. Biol. 13:659-667.
32. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual, p. 92-100. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
33. Hennighausen, L., and B. Fleckenstein. 1986. Nuclear factor 1 interacts with five DNA elements in the promoter region of the cytomegalovirus major immediate early gene. EMBO J. 5:1367-1371.
34. Hoffmann, A., and R. G. Roeder. 1991. Purification of his-tagged proteins in non-denaturing conditions suggests a convenient method for protein interaction studies. Nucleic Acids Res. 19:6337-6338.
35. Holland, C. A., C. Y. Thomas, S. K. Chattopadhyay, C. Koehne, and P. V. O'Donnell. 1989. Influence of enhancer sequences on thymotropism and leukemogenicity of mink cell focus-forming viruses. J. Virol. 63:1284-1292.
36. Hsu, T. Y., T. Möröy, J. Etiemble, A. Louise, C. Trépo, P. Tiollais, and M. A. Buendia. 1988. Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell 55:627-635.
37. Hu, K. Q., and A. Siddiqui. 1991. Regulation of the hepatitis B virus gene expression by the enhancer clement 1. Virology 181:721-726.
38. Huang, J., and T. J. Liang. 1993. A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products. Mol. Cell. Biol. 13:7476-7486.
39. Huang, Z.-M., and T. S. B. Yen. 1994. Hepatitis B virus RNA element that facilitates accumulation of surface transcripts in the cytoplasm. J. Virol. 68:3193-3199.
40. Jones, K. A., J. T. Kadanoga, P. J. Rosenfeld, T. J. Kelly, and R. Tjian. 1987. A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell 48:79-89.
41. Kedzierski, W., and J. C. Porter. 1991. A novel non-enzymatic procedure for removing DNA template from RNA transcription mixtures. BioTechniques 10:210-214.
42. Korba, B, E., P. J. Cote, and J. L. Gerin. 1988. Mitogen-induced replication of woodchuck hepatitis virus in cultured peripheral blood lymphocytes. Science 241:1213-1216.
43. Kuo, C. J., P. B. Conley, L. Chen, F. M. Sladek, J. E. Darnell, and G. R. Crabtree. 1992. A transcriptional hierarchy involved in mammalian cell-type specification. Nature (London) 355:457-461.
44. Lemaigre, F., S. M. Durviaux, and G. G. Rousseau. 1991. Identification of regulatory sequences and protein-binding sites in the liver-type promoter of a gene encoding 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase. Mol. Cell. Biol. 11:1099-1106.
45. Lichtsteiner, S., J. Wuarin, and U. Schibler. 1987. The interplay of DNA-binding proteins on the promoter of the mouse albumin gene. Cell 51:963-973.
46. Lilienbaum, A., B. Crescenzo-Chaigne, A. A. Sail, J. Pillot, and E. Elfassi. 1993. Binding of nuclear factors to functional domains of the duck hepatitis B virus enhancer. J. Virol. 67:6192-6200.
47. Liu, C., W. S. Mason, and J. B. E. Burch. 1994. Identification of factor-binding sites in the duck hepatitis B virus enhancer and in vivo effects of enhancer mutations. J. Virol. 68:2286-2296.
48. Liu, J., E. A. Park, A. L. Gurney, W. J. Roesler, and R. W. Hanson. 1991. Cyclic AMP induction of phosphoenolpyruvate carboxykinase (PEPCK) gene transcription is mediated by multiple promoter elements. J. Biol. Chem. 266:19095-19102.
49. Lovmand, S., N. O. Kjeldgaard, P. Jorgensen, and F. S. Pedersen. 1990. Enhancer functions in U3 of Akv virus: a role for cooperativity of a tandem repeat unit and its flanking DNA sequence. J. Virol. 64:3185-3191.
50. Marion, P. L., M. J. Van Davelaar, S. S. Knight, F. H. Salazar, G. Garcia, H. Popper, and W. S. Robinson. 1986. Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus. Proc. Natl. Acad. Sci. USA 83:4543-4546.
51. Mason, A., M. Wick, H. White, and R. Perrillo. 1993. Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology 18:781-789.
52. Metzger, S., J. L. Halaas, J. L. Breslow, and F. M. Sladek. 1993. Orphan receptor HNF-4 and bZip protein C/EBP alpha bind to overlapping regions of the apolipoprotein B gene promoter and synergistically activate transcription. J. Biol. Chem. 268:16831-16838.
53. Miquerol, L., S. Lopez, N. Cartier, M. Tulliez, M. Raymondjean, and A. Kahn. 1994. Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas. J. Biol. Chem. 269:8944-8951.
54. Miura, N., and K. Tanaka. 1993. Analysis of the rat hepatocyte nuclear factor (HNF) 1 gene promoter: synergistic activation by HNF4 and HNF1 proteins. Nucleic Acids Res. 21:3731-3736.
55. Nagaya, T., T. Nakamura, T. Tokino, T. Tsurimoto, M. Imai, T. Mayumi, K. Kamino, K. Yamamura, and K. Matsubara. 1987. The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma. Genes Dev. 1:773-782.
56. Nishiyori, A., H. Tashiro, A. Kimura, K. Akagi, K.-I. Yamamura, M. Mori, and M. Takiguchi. 1994. Determination of tissue-specificity of the enhancer by combinatorial operation of tissue-enriched transcription factors. J. Biol. Chem. 269:1323-1331.
57. O'Connor, M., and H. U. Bernard. 1995. Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NF1 at a conserved composite regulatory element. Virology 207: 77-88.
58. Ossipow, V., J.-P. Tassan, E. A. Nigg, and U. Schibler. 1995. A mammalian RNA polymerase II holoenzyme containing all components required for promoter-specific transcription initiation. Cell 83:137-146.
59. Popper, H., L. Roth, R. H. Purcell, B. C. Tennant, and J. L. Gerin. 1987. Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc. Natl. Acad. Sci. USA 84:866-870.
60. Pult, I. Personal communication.
61. Raymondjean, M., S. Cereghini, and M. Yaniv. 1988. Several distinct "CCAAT" box binding proteins coexist in eukaryotic cells. Proc. Natl. Acad. Sci. USA 85:757-761.
62. Reijnen, M. J., F. Sladek, R. M. Bertina, and P. H. Reitsma. 1992. Disruption of a binding site for hepatocyte nuclear factor 4 results in haemophilia B Leyden. Proc. Natl. Acad Sci. USA 89:6300-6303.
63. Ringeisen, F. Unpublished data.
64. Rouel, P., G. Raguenez, F. Tronche, V. Mfou'ou, and J.-P. Salier. 1995. Hierarchy and positive/negative interplays of the hepatocyte nuclear factors HNF-1, -3 and -4 in the liver-specific enhancer for the human α-1-microglobulin/bikunin precursor. Nucleic Acids Res. 23:395-404.
65. Scholer, H. R. 1991. Octamania: the POU factors in murine development. Trends Genet. 7:323-329.
66. Shaul, Y., W. J. Rutter, and O. Laub. 1985. A human hepatitis B viral enhancer element. EMBO J. 4:427-430.
67. Sladek, F. M. 1994. Hepatocyte nuclear factor 4 (HNF4). p. 207-230. In F. Tronche and M. Yaniv (ed.), Liver gene expression. R. G. Landes Company, Austin, Tex.
68. Sladek, F. M., W. Zhong, E. Lai, and J. E. Darnell. 1990. Liver-enriched transcription factor HNF4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 4:2353-2365.
69. Sourdive, D., T. Chouard, and M. Yaniv. 1993. The HNF-1 C-terminal domain contributes to transcriptional activity and modulates nuclear localisation. C. R. Acad. Sci. 316:385-394.
70. Stemmer, W. P. C., and S. K. Morris. 1992. Enzymatic inverse PCR: a restriction site independent, single-fragment method for high-efficiency, site-directed mutagenesis. BioTechniques 13:215-220.
71. Stepchenko, A. G. 1994. Noncanonical Oct-sequences are targets for mouse Oct-2B transcription factor. FEES Lett. 337:175-178.
72. Su, H., and J. K. Yee. 1992. Regulation of hepatitis B virus gene expression by its two enhancers. Proc. Natl. Acad. Sci. USA 89:2708-2712.
73. Summers, J., J. M. Smolec, and R. Snyder. 1978. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. Natl. Acad. Sci. USA 75:4533-4537.
74. Transy, C., G. Fourel, W. S. Robinson, P. Tiollais, P. L. Marion, and M. A. Buendia. 1992. Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus. Proc. Natl. Acad. Sci. USA 89:3874-3878.
75. Tronche, F., I. Bach, T. Chouard, B. David-Wattine, M. Pontoglio, F. Ringeisen, D. Sourdive, D. Thépot, and M. Yaniv. 1994. Hepatocyte nuclear factor J (HNF1) and liver gene expression, p. 155-181. In F. Tronche and M. Yaniv (ed.), Liver gene expression. R. G. Landes Company, Austin, Tex.
76. Trujillo, M. A., J. Letrovsky, H. F. Maguire, M. Lopez-Cabrera, and A. Siddiqui. 1991. Functional analysis of a liver-specific enhancer of the hepatitis B virus. Proc. Natl. Acad. Sci. USA 88:3797-3801.
77. Ueda, K., Y. Wei, and D. Ganem. 1996. Activation of N-myc2 gene expression by cis-acting elements of oncogenic hepadnavirus genomes: key role of enhancer II. Virology 217:413-417.
78. Van Lohuizen, M., and A. Berns. 1990. Tumorigenesis by slow-transforming retroviruses-an update. Biochim. Biophys. Acta 1032:213-235.
79. Wang, H. P., and C. E. Rogler. 1991. Topoisomerase I-mediated integration of hepadnavirus DNA in vitro. J. Virol. 65:2381-2392.
80. Wang, J., X. Chenivesse, B. Henglein, and C. Bréchot. 1990. Hepatitis B virus integration in a cyclin A gene in a human hepatocellular carcinoma. Nature (London) 343:555-557.
81. Wefald, F. C., B. H. Delvin, and R. S. Williams. 1990. Functional heterogencity of mammalian TATA-box sequences revealed by interaction with a cell-specific enhancer. Nature (London) 344:260-262.
82. Wei, Y., G. Fourel, A. Ponzetto, M. Silvestro, P. Tiollais, and M. A. Buendia. 1992. Hepadnavirus integration: mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors. J. Virol. 66:5265-5276.
83. Wu, K. J., D. R. Wilson, C. Shih, and G. J. Darlington. 1994 The transcription factor HNF-1 acts with C/EBP alpha to synergistically activate the human albumin promoter through a novel domain. J. Biol. Chem. 269:1177-1182.
84. Yaginuma, K., and K. Koike. 1989. Identification of a promoter region for 3,6-kilobase mRNA of hepatitis B virus and specific cellular binding protein. J. Virol. 63:2914-2920.
85. Yang, D., E. Alt, and C. E. Rogler. 1993. Coordinate expression of N-myc2 and insulin-like growth factor II in pre-cancerous altered hepatic foci in woodchuck hepatitis virus carriers. Cancer Res. 53:2020-2027.
86. Yee, J. K. 1989. A liver-specific enhancer in the core promoter region of human hepatitis B virus. Science 246:658-661.
87. Zhang, P., and A. McLachlan. 1994. Differentiation-specific transcriptional regulation of the hepatitis B virus nucleocapsid gene in human hepatoma cell lines. Virology 202:430-440.
88. Zhang, P., A. K. Raney, and A. McLachlan. 1993. Characterization of functional Sp1 transcription factor binding sites in the hepatitis B virus nucleocapsid promoter. J. Virol. 67:1472-1481.